Step 7 of 9
Heart diseases without shunting: obstructions and valvular heart diseases
Fixed congenital ventricular outflow obstructions (pulmonary or aortic valvular stenosis, subaortic membrane, PA or aortic hypoplasia) cause concentric left or right ventricular hypertrophy (RVH or LVH). Two constraints play a critical role in how these cases are managed [1].
- The need to maintain contractility, which is essential for retaining an ability to generate high pressures. The threat of systolic failure is ever present;
- Diastolic failure typical of ventricular hypertrophy, which makes systolic volume highly dependent on preload; filling pressures are higher for the same end-diastolic volume. Hypovolaemia and loss of atrial systole are poorly tolerated.
A severe obstruction of the aortic arch (hypoplasia, coarctation) can cause systemic hypoperfusion with metabolic acidosis and mesenteric ischaemia. In cases of valvular or subvalvular aortic stenosis, systemic hypotension may cause myocardial ischaemia due to a fall in coronary perfusion pressure [2].
In cases of muscular aortic and pulmonary stenosis (infundibular), the dynamic aspect is dominant – the stenosis effect increases with contractility and is reduced by β-blockade. The obstruction is reduced by a negative inotropic effect, increased circulating volume (hypervolaemia), and increased afterload (α vasocontrictors). Any β catecholaminergic stimulation must be avoided.
Valvular regurgitation causes eccentric ventricular hypertrophy with volume overload and increased filling pressure. It is highly sensitive to variations in afterload – mitral insufficiency (MI) or aortic insufficiency (AI) increase if SVR rises. In severe cases of tricuspid insufficiency (Ebstein anomaly) or pulmonary insufficiency (PI), regurgitation is exacerbated by rising PVR.
In cases of muscular aortic and pulmonary stenosis (infundibular), the dynamic aspect is dominant – the stenosis effect increases with contractility and is reduced by β-blockade. The obstruction is reduced by a negative inotropic effect, increased circulating volume (hypervolaemia), and increased afterload (α vasocontrictors). Any β catecholaminergic stimulation must be avoided.
Valvular regurgitation causes eccentric ventricular hypertrophy with volume overload and increased filling pressure. It is highly sensitive to variations in afterload – mitral insufficiency (MI) or aortic insufficiency (AI) increase if SVR rises. In severe cases of tricuspid insufficiency (Ebstein anomaly) or pulmonary insufficiency (PI), regurgitation is exacerbated by rising PVR.
Obstructive lesions and valvular heart diseases |
Outflow obstructions cause concentric ventricular hypertrophy characterised by:
- Diastolic dysfunction - Threat of systolic dysfunction - Threat of myocardial ischaemia Valvular insufficiencies are exacerbated by rising ventricular afterload |
© BETTEX D, BOEGLI Y, CHASSOT PG, June 2008, last update May 2018
References
- SCHMITZ ML, ULLAH S. Anesthesia for right-sided obstructive lesions. In : ANDROPOULOS DA, et al, eds. Anesthesia for congenital heart disease. Oxford: Blackwell-Futura, 2005, 328-45
- SILVERSIDES CK, KIESS M, BEAUCHESNE L, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol 2010; 26:e80-e97
14. Anesthesia for paediatric heart surgery
- 14.1 Introduction
- 14.2 Pathophysiology
- 14.3 Haemodynamic strategies
- 14.3.1 Classification
- 14.3.2 Left-to-right shunt and high pulmonary blood flow
- 14.3.3 Pulmonary hypertension in children
- 14.3.4 Cyanotic right → left shunt and reduced pulmonary blood flow
- 14.3.5 Cyanotic right → left shunt and reduced systemic blood flow
- 14.3.6 Bidirectional cyanotic shunt
- 14.3.7 Heart diseases without shunting: obstructions and valvular heart diseases
- 14.3.8 Treatment options for neonates
- 14.3.9 Drug therapy
- 14.4 Anaesthetic technique
- 14.5 CPB in children
- 14.6 Anaesthesia for specific pathologies
- 14.6.1 Introduction
- 14.6.2 Anatomical landmarks
- 14.6.3 Anomalous venous returns
- 14.6.4 Atrial septal defects (ASDs)
- 14.6.5 Atrioventricular canal (AVC) defects
- 14.6.6 Ebstein anomaly
- 14.6.7 Anomalies of the atrioventricular valves
- 14.6.8 Ventricular septal defects (VSDs)
- 14.6.9 Ventricular hypoplasia
- 14.6.10 Tetralogy of Fallot
- 14.6.11 Double outlet right ventricle (DORV)
- 14.6.12 Pulmonary atresia
- 14.6.13 Anomalies of the left ventricular outflow
- 14.6.14 Transposition of the great arteries (TGA)
- 14.6.15 Truncus arteriosus
- 14.6.16 Coarctation of the aorta
- 14.6.17 Arterial abnormalities
- 14.6.18 Heart transplantation
- 14.7 Conclusions